文献速递冠心病血脂与心血管预防

急性冠脉综合征后双联抗血小板治疗出血风险预测模型

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
PubMed 文献 · Heart · 2017-04-05

基于TRILOGY ACS试验中9240例未行血运重建的不稳定心绞痛/NSTEMI患者,开发并验证双联抗血小板治疗期间出血风险的纵向预测模型。模型对GUSTO严重/危及生命/中度出血的C指数为0.78,对TIMI主要或次要出血为0.67;外部验证GUSTO模型C指数降至0.69,TIMI模型为0.68。作者认为该模型可辅助权衡DAPT时程的风险获益。

要点

  • 年龄、性别、体重、NSTEMI、随机前造影、消化性溃疡史、肌酐、收缩压、血红蛋白和β受体阻滞剂是非CABG相关GUSTO出血的10个基线预测因子。
  • TIMI主要或次要出血的5个预测因子为年龄、性别、随机前造影、肌酐和血红蛋白。
  • GUSTO模型内部验证C指数0.77,外部验证0.69;TIMI模型内部验证0.65,外部验证0.68。

核心结论

  • 急性冠脉综合征患者接受双联抗血小板治疗期间的纵向出血风险可通过所选基线特征可靠预测。
  • TRILOGY ACS出血模型可辅助权衡急性冠脉综合征后双联抗血小板治疗的时程风险获益。

研究设计与样本

  • 基于TRILOGY ACS试验的纵向出血风险预测模型开发与验证研究,纳入9240例未行血运重建的不稳定心绞痛/非ST段抬高型心肌梗死患者,双联抗血小板治疗中位14.8个月。

主要发现

  • 非CABG相关GUSTO严重/危及生命/中度出血的10个显著基线预测因子为年龄、性别、体重、NSTEMI(对比不稳定心绞痛)、随机前造影、既往消化性溃疡病、肌酐、收缩压、血红蛋白和β受体阻滞剂治疗。
  • TIMI主要或次要出血的5个显著基线预测因子为年龄、性别、随机前造影、肌酐和血红蛋白。
  • GUSTO模型Therneau C指数为0.78(SE=0.024),TIMI模型为0.67(SE=0.023)。
  • 内部bootstrapping验证C指数分别为0.77和0.65。
  • 外部验证GUSTO模型C指数为0.69,TIMI模型为0.68。

临床怎么用

  • 原文结论指出该模型可辅助急性冠脉综合征后双联抗血小板治疗时程的风险获益权衡,未给出具体临床应用推荐。

局限性

  • 外部验证中GUSTO模型C指数由0.78降至0.69,预测准确性有所衰减。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Dual antiplatelet therapy (DAPT) with aspirin + a P2Y12 inhibitor is recommended for at least 12 months for patients with acute coronary syndrome (ACS), with shorter durations considered for patients with increased bleeding risk. However, there are no decision support tools available to predict an individual patient's bleeding risk during DAPT treatment in the post-ACS setting. METHODS: To develop a longitudinal bleeding risk prediction model, we analy sed 9240 patients with unstable angina/non-ST segment elevation myocardial infarction (NSTEMI) from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial, who were managed without revasculari sation and treated with DAPT for a median of 14.8 months. RESULTS: We identified 10 significant baseline predictors of non-coronary artery bypass grafting (CABG)-related Global Use of Strategies to Open Occluded Arteries (GUSTO) severe/life-threatening/moderate bleeding: age, sex, weight, NSTEMI (vs unstable angina), angiography performed before randomi sation, prior peptic ulcer disease, creatinine, systolic blood pressure, haemoglobin and treatment with beta-blocker. The five significant baseline predictors of Thrombolysis In Myocardial Infarction (TIMI) major or minor bleeding included age, sex, angiography performed before randomi sation, creatinine and haemoglobin. The models showed good predictive accuracy with Therneau's C-indices: 0.78 (SE = 0.024) for the GUSTO model and 0.67 (SE = 0.023) for the TIMI model. Internal validation with bootstrapping gave similar C-indices of 0.77 and 0.65, respectively. External validation demonstrated an attenuated C-index for the GUSTO model (0.69) but not the TIMI model (0.68). CONCLUSIONS: Longitudinal bleeding risks during treatment with DAPT in patients with ACS can be reliably predicted using selected baseline characteristics. The TRILOGY ACS bleeding models can inform risk -benefit considerations regarding the duration of DAPT following ACS. TRIAL REGISTRATION: ClinicalTrials.gov identifier: https://clinicaltrials.gov/ct2/show/NCT00699998.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Alfredsson J, Neely B, Neely ML, et al. Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes. Heart. 2017. PMID: 28381584. doi:10.1136/heartjnl-2016-310090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。